Neo Ivy Capital Management

Position in PFE — Pfizer Inc

CIK 1727783 NEW YORK, NY

Position in PFE

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$3,481,052

-$18,120 QoQ

Shares Held

144,562

+2.9% QoQ

Ownership

0.003%

of shares outstanding

% of Portfolio

0.81%

of 13F equity value

Holder Rank

#752

of 2,821 holders

Holding Since

Jun 2020

16 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Neo Ivy Capital Management holds $8,085,964 across 5 Drug Manufacturers - General names. PFE ranks #1 (43.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	PFE	Pfizer Inc This page	144,562	$3,481,052
2	BMY	Bristol Myers Squibb Co	54,404	$3,134,758
3	ABBV	AbbVie Inc.	3,502	$881,243
4	MRK	Merck & Co., Inc.	3,119	$400,791
5	GILD	Gilead Sciences, Inc.	1,489	$188,120

16 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$3,481,052	144,562	+2.9%	Shares	Sole	2026-08-14
2025-12-31	$3,499,172	140,529	+259.0%	Shares	Sole	2026-02-13
2025-09-30	$997,440	39,146	-67.7%	Shares	Sole	2025-11-12
2025-06-30	$2,939,924	121,284	+56.0%	Shares	Sole	2025-08-12
2025-03-31	$1,969,982	77,742	-44.7%	Shares	Sole	2025-05-06
2024-12-31	$3,726,324	140,457	+82.0%	Shares	Sole	2025-02-18
2024-09-30	$2,233,241	77,168	+1261.5%	Shares	Sole	2024-11-18
2024-06-30	$158,590	5,668	-70.7%	Shares	Sole	2024-07-19
2023-09-30	$641,109	19,328	+1143.8%	Shares	Sole	2023-11-30
2022-06-30	$81,476	1,554	-79.8%	Shares	Sole	2022-08-16
2022-03-31	$397,593	7,680	-68.9%	Shares	Sole	2022-05-16
2021-09-30	$1,060,970	24,668	+31.4%	Shares	Sole	2021-11-16
2021-06-30	$735,229	18,775	+296.9%	Shares	Sole	2021-08-16
2021-03-31	$171,367	4,730	-74.0%	Shares	Sole	2021-10-07
2020-09-30	$667,021	18,175	-26.3%	Shares	Sole	2020-11-17
2020-06-30	$806,644	24,668	—	Shares	Sole	2020-08-17
No filing history on record for this holder in this stock.